Targeting cancer metabolism through synthetic lethality-based combinatorial treatment strategies

Area of Science:

• Oncology
• Cancer Metabolism
• Drug Discovery

Background:

• Cancer cells exhibit significant metabolic alterations impacting more than just energy production.
• Understanding these metabolic dependencies is crucial for developing effective cancer therapies.

Purpose of the Study:

• To review the latest strategies for targeting glucose and glutamine metabolism in cancer therapy.
• To emphasize novel combinatorial treatment approaches for cancer metabolism.

Main Methods:

• Review of preclinical and clinical investigations of inhibitors targeting glucose, lactate, and glutamine metabolism.
• Analysis of cell-intrinsic and cell-extrinsic factors influencing metabolic dependencies.

Main Results:

• Small molecule inhibitors targeting cancer metabolism are progressing through clinical trials.
• Rational, synthetic lethality-based strategies are being developed to exploit metabolic vulnerabilities.
• Advances in understanding metabolic dependencies inform new drug target identification.

Conclusions:

• Targeting cancer metabolism, particularly glucose and glutamine pathways, is a promising therapeutic strategy.
• Combinatorial approaches and synthetic lethality offer potential for enhanced cancer treatment efficacy.
• Elucidating context-specific metabolic dependencies can lead to novel drug targets.